CORAR Leadership
CORAR Executive Director
Michael J. Guastella, MS, MBA - Executive Director
Before joining CORAR in 2011, Michael held various sales and marketing leadership roles in the imaging, biotechnology, clinical laboratory, and radiopharmaceutical industries and was most recently the Vice President of Marketing and Product Development for Cardinal Health Nuclear Pharmacy Services. Michael has served on the CORAR Board of Directors for 10 years and has held other industry leadership positions including Co-Chairman of the CORAR Healthcare Policy Committee – Reimbursement. Michael received his B.S. and M.S. degrees from UCLA and earned his MBA from the UCLA Anderson School of Management.
2025 CORAR Corporate Officers
Chairman
David Pellicciarini - Vice President Industry Affairs and Corporate Radiation Safety Officer Cardinal Health Nuclear & Precision Health Solutions
Vice Chairman
Shahe Bagerdjian - President International Isotopes, Inc.
Secretary/Treasurer
James T. Harvey - Senior Vice President & Chief Science Officer NorthStar Medical Radioisotopes, LLC
2025 CORAR Board Members
Shahe Bagerdjian (International Isotopes, Inc.)
Roy W. Brown (Curium)
Scott Claunch (TerraPower Isotopes)
Shane Cobb (Perspective Therapeutics, Inc)
James Cook (Evergreen Theragnostics, Inc.)
Roger Estafanos (ITM USA, Inc.)
Shaemus Gleason (Clarity Pharmaceuticals)
Ira Goldman (Lantheus)
James T. Harvey PhD (NorthStar Medical Technologies, LLC)
Ben Hickey (RayzeBio, a Bristol Myers Squibb Company)
Rohan Jain (Nusano, Inc)
Campbelle Mongilia (SUN Radiopharma)
Michael Pintek (Cardinal Health Nuclear & Precision Health Solutions)
Vittorio Puppo (BWXT Medical)
Eric Schutt (SHINE Technologies LLC)
Dominic Siewko (Nucleus RadioPharma)
Jay Simon (Eckert & Ziegler Radiopharma, Inc.)
Patrick Smith (University of Missouri Research Reactor (MURR))
Geoff Towle (Radioligand Therapies Advanced Accelerator Applications, a Novartis Company)
Chris Wagner (Eden Radioisotopes, LLC)
Jim Wilson (Eckert & Ziegler Isotope Products, Inc.)
Latest News
-
MITA and CORAR Support House Bill to Foster Access to Innovative Medical Imaging https://t.co/Riwxdv6noS #CORAR
-
CORAR Comments on FDA Draft 503B RP Compounding Guidance https://t.co/EJMpjHYcz4 #CORAR
-
CORAR Comments on FDA Draft Nuclear Pharmacy Compounding Guidance https://t.co/Hhcem9KabR #CORAR